This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health. According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, healthinformation interoperability is facilitated with the use of blockchain.
Regulatory Landscape: Regulatory Clarity: Clearer regulatory frameworks for digital healthtechnologies will foster investor confidence and higher valuations. Companies specialising in AI-driven medical imaging, drugdevelopment, and predictive analytics are likely to see substantial valuation increases.
The increasing adoption of digital healthtechnologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Health IT and Interoperability: HealthInformation Exchange (HIE): HIE companies will continue to merge to create larger, more comprehensive networks.
In 2025, B2C2B models are poised to become increasingly prominent in healthcare, driven by several key factors: Digital Health Boom: The rapid growth of digital healthtechnologies, such as telehealth, wearable devices, and AI-powered diagnostics, is creating new opportunities for B2C2B companies to reach both patients and healthcare providers.
Biotechnology: This is the use of living organisms to develop new medical products and services. Healthinformationtechnology (HIT): This refers to the use of informationtechnology to store, manage, and analyze healthcare data. Examples include telehealth, e-prescriptions, and patient portals.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content